- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
Current Understanding Of IgA Nephropathy (IgAN)
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Current Understanding Of IgA Nephropathy (IgAN)
Background
IgA Nephropathy (IgAN) is an autoimmune disease characterized by the production of abnormal IgA, an immune response, and deposits of IgA-containing immune complexes in glomeruli causing damage1. Which left unaddressed, the relentless damage to glomeruli can lead to kidney failure and the need for renal replacement therapy, such as transplant or dialysis2. The current model of pathogenicity involves four hits that drive the disease development and progression2.
Did You Know?
- Immunoglobulin A Nephropathy (IgAN), also known as Berger’s disease, is the most common glomerulonephritis worldwide1
- Of those affected with IgAN, 20-40% progress to kidney failure1
- Join us for our webinar where expert, Dr. Ankur Shah, will provide an overview of IgA Nephropathy
- Prevalence, epidemiology, and pathogenesis of IgAN
- Signs and symptoms of IgAN
- Diagnosis and general management strategies of IgAN per KDIGO guidelines
- NephU_Overview of IgAN_2022 Infographic – US.CORP.X.22.00054
- NephU_The “Four Hit” IgA Nephropathy (IgAN) Pathogenesis Theory_2022 Infographic – US.CORP.X.22.00055
Featuring
Ankur Shah, MD
Assistant Professor of Medicine and Associate Program Director of the Nephrology Fellowship training programWarren Alpert Medical School, Brown University*
Ankur Shah, MD is Assistant Professor of Medicine and Associate Program Director of the Nephrology Fellowship training program at the Warren Alpert Medical School of Brown University. He completed residency in internal medicine at Temple University Hospital, followed by fellowship at the Hospital of the University of Pennsylvania, where he served as chief fellow and received advanced training in medical education. His primary interests are home dialysis including both peritoneal dialysis and home hemodialysis, topics in which he has published numerous peer reviewed articles as well as textbook chapters and has lectured both nationally and internationally. He is a decorated educator having mentored dozens of medical students, residents, and fellows and received the dean’s excellence in teaching award, department of medicine teaching award, and nephrology fellowship teaching awards at Brown and is a winner of the American Society of Nephrology’s Innovations in Kidney Education contest. He is a Fellow of the American Society of Nephrology, the National Kidney Foundation, and the American College of Physicians.
Moderating
Josh Gariboldi, PharmD, BCPS
Nephrology Senior Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Josh Gariboldi, PharmD, BCPS joined Otsuka in January 2021 and is a Medical Science Liaison on our Nephrology East Team, covering the Carolinas and Tennessee. Dr Gariboldi earned his Doctor of Pharmacy degree from the University of Florida in 2012. He has more than eight years of experience as a clinical pharmacist in both the community and hospital settings, most recently at Bon Secours Mercy Health St. Francis Hospital in Greenville, SC. Dr Gariboldi served as a preceptor with Presbyterian College School of Pharmacy, where he instructed students on Advanced Pharmacy Practice rotations. He holds board certifications in both pharmacotherapy and medical affairs.
Hannah N. Lambert, PharmD
Nephrology Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Hannah N. Lambert is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy and completed her clinical residency training at Xavier University of Louisiana College of Pharmacy in New Orleans, LA. Prior to joining Otsuka, Dr Lambert was a clinical pharmacist at Ochsner Health in Digital Medicine.
*Dr Shah is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Josh Gariboldi and Hannah Lambert are employees of OPDC.
Registration
Related Events
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
